Jan Blatný

3.1k total citations
130 papers, 2.1k citations indexed

About

Jan Blatný is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jan Blatný has authored 130 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 35 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Jan Blatný's work include Hemophilia Treatment and Research (35 papers), Platelet Disorders and Treatments (24 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). Jan Blatný is often cited by papers focused on Hemophilia Treatment and Research (35 papers), Platelet Disorders and Treatments (24 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). Jan Blatný collaborates with scholars based in Czechia, Norway and United Kingdom. Jan Blatný's co-authors include Svein Valla, Trygve Brautaset, Hanne C. Winther‐Larsen, Gunnar Skogan, Marius Dybwad, Kåre Haugan, Per Einar Granum, Else Marie Fykse, Jaran Strand Olsen and Ingolf F. Nes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Blood.

In The Last Decade

Jan Blatný

113 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Blatný Czechia 25 784 393 348 333 305 130 2.1k
Francisco Rodríguez‐Quiñones United Kingdom 9 1.1k 1.4× 684 1.7× 362 1.0× 375 1.1× 112 0.4× 14 2.8k
Jim Cavet United Kingdom 32 949 1.2× 205 0.5× 699 2.0× 138 0.4× 514 1.7× 70 2.9k
Francesca Berlutti Italy 32 726 0.9× 188 0.5× 217 0.6× 130 0.4× 52 0.2× 82 2.7k
Stephen P. Kidd Australia 29 969 1.2× 286 0.7× 37 0.1× 306 0.9× 292 1.0× 86 2.6k
Yao Wang China 31 1.7k 2.2× 639 1.6× 103 0.3× 270 0.8× 77 0.3× 119 5.1k
David G. Kehres United States 15 420 0.5× 240 0.6× 239 0.7× 82 0.2× 162 0.5× 18 1.4k
Mathieu Cellier Canada 27 715 0.9× 258 0.7× 883 2.5× 75 0.2× 291 1.0× 46 3.0k
Brent Gilpin New Zealand 27 799 1.0× 129 0.3× 48 0.1× 247 0.7× 155 0.5× 81 2.7k
Catherine Daniel France 30 1.1k 1.4× 267 0.7× 46 0.1× 122 0.4× 227 0.7× 71 2.7k
J E Arceneaux United States 22 547 0.7× 311 0.8× 133 0.4× 148 0.4× 84 0.3× 34 1.4k

Countries citing papers authored by Jan Blatný

Since Specialization
Citations

This map shows the geographic impact of Jan Blatný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Blatný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Blatný more than expected).

Fields of papers citing papers by Jan Blatný

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Blatný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Blatný. The network helps show where Jan Blatný may publish in the future.

Co-authorship network of co-authors of Jan Blatný

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Blatný. A scholar is included among the top collaborators of Jan Blatný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Blatný. Jan Blatný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carção, Manuel, Christoph Königs, Nadine G. Andersson, et al.. (2025). Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors – lessons learned from the PedNet prospective cohort study. Journal of Thrombosis and Haemostasis. 23(10). 3134–3147.
2.
Caram‐Deelder, Camila, Hellen McKinnon Edwards, Thomas van den Akker, et al.. (2024). Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage. Journal of Clinical Medicine. 13(9). 2656–2656. 2 indexed citations
3.
Holme, Pål André, Jan Blatný, Riitta Lassila, et al.. (2024). Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A. Haemophilia. 30(5). 1109–1114. 3 indexed citations
4.
Carção, Manuel, et al.. (2024). How much prophylaxis is enough in haemophilia?. Haemophilia. 30(S3). 86–94. 1 indexed citations
5.
Blatný, Jan, Cristina Catarino, G. Dolan, et al.. (2024). Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions. Therapeutic Advances in Hematology. 15. 1574202903–1574202903.
6.
Kozubík, Kateřina Staňo, Magdalena Skalnı́ková, Tomáš Loja, et al.. (2024). A novel thrombocytopenia‐4‐causing CYCS gene variant decreases caspase activity: Three‐generation study. British Journal of Haematology. 205(6). 2450–2458. 5 indexed citations
7.
Ranta, Susanna, Jayashree Motwani, Jan Blatný, et al.. (2023). Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres. Haemophilia. 29(5). 1291–1298. 8 indexed citations
8.
Blatný, Jan, et al.. (2023). Capnometry during neonatal transport—Mini review. Acta Paediatrica. 112(5). 919–923. 1 indexed citations
11.
Komenda, Martin, Vladimír Černý, Jiří Jarkovský, et al.. (2021). Control Centre for Intensive Care as a Tool for Effective Coordination, Real-Time Monitoring, and Strategic Planning During the COVID-19 Pandemic. Journal of Medical Internet Research. 24(2). e33149–e33149. 4 indexed citations
12.
Blanchette, Victor S., David Lillicrap, Shannon Jackson, et al.. (2018). A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a. Blood. 132(Supplement 1). 2480–2480. 1 indexed citations
13.
Jj, Michiels, Ondřej Zapletal, Miroslav Penka, et al.. (2018). Determination of Two Rapid Von Willebrand Factor (VWF) Activity assays VWF: Gpibm and VWF: Gpibr in Well Defined Von Willebrand Disease Patients Using a Complete Set of Classical and Sensitive VWF Assays. 6(6). 1–15. 3 indexed citations
14.
Fykse, Else Marie, Torbjörn Tjärnhage, Tarmo Humppi, et al.. (2015). Identification of airborne bacteria by 16S rDNA sequencing, MALDI-TOF MS and the MIDI microbial identification system. Aerobiologia. 31(3). 271–281. 27 indexed citations
15.
Blatný, Jan, et al.. (2014). Detection of Legionella pneumophila in a biological treatment plant by co-cultivatiobn with Acanthamoeba castellanii. Computers & Electrical Engineering. 1(2). 91–99. 2 indexed citations
16.
Madslien, Elisabeth Henie, et al.. (2012). Genotyping of B. licheniformisbased on a novel multi-locus sequence typing (MLST) scheme. BMC Microbiology. 12(1). 230–230. 27 indexed citations
17.
Křenová, Zdenka, Jan Blatný, Martin Falk, et al.. (2011). Extraosseal Ewing Sarcoma as a Rare Cause of the Blueberry Muffin Baby Syndrome: A Case Report and the Review of the Literature. American Journal of Dermatopathology. 33(7). 733–735. 4 indexed citations
18.
Blatný, Jan, Petra Ovesná, Petr Brabec, et al.. (2010). [Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic].. PubMed. 75(4). 297–305.
19.
Blatný, Jan. (2009). Krvácení a jeho léčba - (nejen) hematologický problém. Interní medicína pro praxi. 11(3). 120–122.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026